Annette Kleiser
Chief Executive Officer at Dalan Animal Health, Inc.
Annette Kleiser active positions
| Companies | Position | Start | End |
|---|---|---|---|
Dalan Animal Health, Inc.
 Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Director/Board Member | - | - |
| Chief Executive Officer | 01/12/2018 | - |
Career history of Annette Kleiser
Former positions of Annette Kleiser
| Companies | Position | Start | End |
|---|---|---|---|
| ALLON THERAPEUTICS INC. | Corporate Officer/Principal | 27/08/2007 | 01/09/2008 |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Training of Annette Kleiser
| Universität Konstanz | Graduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistics
International
| Germany | 3 |
| United States | 3 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALLON THERAPEUTICS INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Dalan Animal Health, Inc.
Dalan Animal Health, Inc. BiotechnologyHealth Technology Dalan Animal Health, Inc. is a company that focuses on providing animal health solutions to support a more sustainable future. The company is based in Athens, GA, at the University of Georgia's innovation hub. The company uses a platform vaccine technology that allows the maternal animal to pass immune modulators to the next generation larvae before they hatch. The company plans to develop vaccines for other honeybee diseases and underserved industries, such as shrimp, mealworms, and insects used in agriculture. The CEO of the company is Annette Kleiser. | Health Technology |
- Stock Market
- Insiders
- Annette Kleiser
- Experience
